The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice - Wikidata - awgldk - TriplyDB

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

http://www.wikidata.org/entity/Q33897937

about

Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux Dietary alpha-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter LRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol export ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux Nuclear receptors as drug targets for metabolic disease.Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivo Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.Rutaecarpine suppresses atherosclerosis in ApoE-/- mice through upregulating ABCA1 and SR-BI within RCT.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Liver-directed gene therapy for dyslipidemia and diabetes Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues.Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.Regulation and mechanisms of macrophage cholesterol efflux ABCA1: regulation, trafficking and association with heteromeric proteins.Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.Corticotropin-Releasing Hormone (CRH) Promotes Macrophage Foam Cell Formation via Reduced Expression of ATP Binding Cassette Transporter-1 (ABCA1).Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses.Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse Reverse cholesterol transport and cholesterol efflux in atherosclerosis.Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis.Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.Lanatoside C Promotes Foam Cell Formation and Atherosclerosis Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α.Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis Betulin attenuates atherosclerosis in apoE-/- mice by up-regulating ABCA1 and ABCG1.Renal dysfunction potentiates foam cell formation by repressing ABCA1.Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.Liver X Receptor: Crosstalk Node for the Signaling of Lipid Metabolism, Carbohydrate Metabolism, and Innate Immunity.Micro-RNAs and High-Density Lipoprotein Metabolism.Vascular function during prolonged progression and regression of atherosclerosis in mice.The application of phenotypic high-throughput screening techniques to cardiovascular research.Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?The protein cargo of HDL: implications for vascular wall biology and therapeutics.

P2860

Q23909545-868B0EB8-B866-4BF7-84F2-51A2BC8EDA8A Q24303527-E39BC03F-EA03-47F1-8E66-123D788437B2 Q24337138-DD349E02-5512-4147-BFF9-D223177925D3 Q24648844-BC7F3E9C-7877-44CA-9E14-50612DBB9DC0 Q28506217-4AA086D6-269E-4D94-A4C6-A16B5B896CF2 Q28506509-3DF2A7AA-E40E-41B5-A7E1-92ADE8F8A316 Q28569109-BBDB7738-EFCF-4DBB-9F01-4C51F8733122 Q28588482-70A8051B-5919-4000-BA62-5C59CB103E50 Q30430126-9727C291-0D6E-4561-B092-30C282A2F3A3 Q33589194-10A1736B-7B2F-42A2-940D-A65CA5DB319A Q33811098-8B008D8F-DD22-42EF-918E-A462C5787834 Q33945072-5B800C8D-096B-49DC-95F6-1B72D95FD6F0 Q33993233-DCFD2305-9C30-4AEC-B4F3-71F813D0FD9B Q34016399-BA23EDFC-16FB-49B2-B234-43FBEE0C03D8 Q34028934-21EA54B0-773F-429A-B45F-C2131C5BAE7B Q34261102-FAECE078-9600-4334-8B6B-A1135287E380 Q34722551-7EBC7788-35A5-42EB-BAA8-50002BDDF306 Q34798750-1A7828A2-B058-4A27-8428-B44B0937096B Q35009337-D927F9A3-791A-44B7-808F-1EC8439515C6 Q35625936-3DEFE8CB-9E9C-4D64-A12E-0CC267468138 Q35674458-9DD6622E-1007-4777-86B2-CC19CFCB2E09 Q35848129-5F466060-082F-4C6B-9984-FF5F11CF04D3 Q36082700-E991FC12-7C65-4177-A634-4CB673087225 Q36094424-FEB39743-2988-453A-A51F-50F4A19E978D Q36300834-5D492BA6-0857-4BA1-839D-E3C2974FFA01 Q36304339-49B76247-241F-4AD7-A360-D3EEF6C01406 Q36383616-786A2F86-310F-47A4-81F0-51401AEC4E0A Q36516946-70B2997E-8B44-4431-94CF-18B5F3CB7ED9 Q37009960-BB20636C-0AB3-4FB4-84E1-A5F5F9835908 Q37151837-41C5CBEB-83C7-4774-A9AA-80317012BFAF Q37221654-3C88FC28-22AD-4971-9E8B-12010D34513B Q37325671-FC1409D6-3A14-4030-A675-3B2F757B2F05 Q37357219-68045790-976B-4274-B0A5-EB596F3EF34D Q37370803-2F5E299A-3922-4CB2-869A-18D34AB40EB4 Q37597310-09C6FFF4-D608-4C64-AF65-0CF321C734E4 Q37650114-D822272B-CE5B-4C70-AFF5-6DD21E8BC07E Q37651668-3DC5BADD-1B8F-4131-8C06-CB6AE57CC621 Q37704724-9FD401DE-C596-4E60-9D5E-E748A28230DC Q37707402-DC272D99-042D-4548-9F7A-C5A0EA13FD4D Q37803127-21F211BE-4DA2-41D6-A956-B7D564D00762

P2860

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

http://www.wikidata.org/entity/Q33897937

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@ast

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@en

type

label

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@ast

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@en

prefLabel

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@ast

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@en

P1433

Q33897937-CE1F931C-29FB-43C6-9896-44551C858EB3

P1476

Q33897937-B5C45340-3550-4F76-B20B-65CCFD8E2F8B

P2093

Q33897937-0043A710-9554-4E31-B9F1-A715FB9BDC82

Q33897937-5289AF3C-AC6E-4377-9862-3108C788A421

Q33897937-5408CBB8-B1F9-4A3E-9E0D-E40BAB617E4E

Q33897937-691F78E2-D237-4E1B-B79A-3BF80C227B54

Q33897937-8AEE2B52-D85D-4F16-AD72-28D7D563004C

Q33897937-939BCF54-A060-4983-BAB9-844D8A080C99

Q33897937-A1A0BAF6-68B8-435F-8971-6BF0EC1F4ABF

Q33897937-A743A383-3280-4C2A-BFEC-66421E6FB224

Q33897937-AD807F3E-A1B8-45B9-9AE8-739C19F18E49

Q33897937-B23F6E06-8B1E-4FD0-B3AA-44F5E9CF79C8

P2860

Q33897937-35A5FAC9-9643-4A16-9C8D-09CA79FD8E22

Q33897937-3819C133-BD35-4915-B647-41D0376B2880

Q33897937-43D10038-EC5F-4517-9624-5E94686ACEC7

Q33897937-46686742-34D9-4E45-B3A9-7214A544E367

Q33897937-4BC79D0A-CC83-432C-B5A1-BB24D4BCD048

Q33897937-55158092-1D02-41A8-9EA0-44AC5C742B90

Q33897937-559FB504-EED8-4AF4-B7D1-DE230FFB7C74

Q33897937-5B083D9D-6835-4916-892B-950335C10673

Q33897937-5D0F7315-BCA8-4B13-A6FB-C8164AA36495

Q33897937-667C2261-D0ED-49F3-8A99-92ADB79C7053

P304

Q33897937-A7910CEF-BC9A-49AE-9260-F50FE28EBE45

P31

Q33897937-B1E62872-3286-4131-A717-70D35043541F

P356

Q33897937-E02062E7-04D8-43EC-8752-74AF9756A7DB

P407

Q33897937-1D4EB4A6-F986-4B77-AAEF-77AE69392C5E

P433

Q33897937-7EDBFB0B-A181-4BF9-94B6-6983226D93C1

P478

Q33897937-0FE41F89-42D3-4448-B3A3-E101FA85B57E

P50

Q33897937-46A98AB0-FDE4-497E-87E2-051BB017DA28

P577

Q33897937-1DC25485-0181-491A-926D-158B855CEAA2

P5875

Q33897937-64134C4A-995A-4DE9-AFD3-A149578F746A

P698

Q33897937-12BC77F4-8B16-490B-BDD5-568E284AA7D5

P921

Q33897937-65EE1346-6296-4F30-A551-2A452BCA86CE

Q33897937-BB4228ED-FC36-4082-9161-C08E20A4CBE9

Q33897937-D8F06636-5621-4EB8-BA5B-2173BE1AE90D

P932

Q33897937-D52CDD5B-EB63-4308-921B-09EE7BB6D450

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The ATP binding cassette trans ...... C57BL/6 and apoE-knockout mice

@en

P2093

Alan T Remaley

http://www.w3.org/2001/XMLSchema#string

Beverly Paigen

http://www.w3.org/2001/XMLSchema#string

Boris L Vaisman

http://www.w3.org/2001/XMLSchema#string

Charles W Joyce

http://www.w3.org/2001/XMLSchema#string

Donald S Fredrickson

http://www.w3.org/2001/XMLSchema#string

Edward D Neufeld

http://www.w3.org/2001/XMLSchema#string

H Bryan Brewer

http://www.w3.org/2001/XMLSchema#string

Jamila Najib-Fruchart

http://www.w3.org/2001/XMLSchema#string

Marcelo J A Amar

http://www.w3.org/2001/XMLSchema#string

Robert F Hoyt

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

The pathogenesis of atherosclerosis: a perspective for the 1990s

P304

407-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.012587699

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11605727

http://www.w3.org/2001/XMLSchema#string

P698

11752403

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

117573

http://www.w3.org/2001/XMLSchema#string